Does AZD-1222 Cause Multiple sclerosis relapse? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Multiple sclerosis relapse have been filed in association with AZD-1222. This represents 0.7% of all adverse event reports for AZD-1222.
17
Reports of Multiple sclerosis relapse with AZD-1222
0.7%
of all AZD-1222 reports
0
Deaths
11
Hospitalizations
How Dangerous Is Multiple sclerosis relapse From AZD-1222?
Of the 17 reports, 11 (64.7%) required hospitalization.
Is Multiple sclerosis relapse Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AZD-1222. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does AZD-1222 Cause?
Headache (838)
Fatigue (784)
Pyrexia (735)
Pain (579)
Covid-19 (515)
Arthralgia (508)
Nausea (494)
Palpitations (485)
Dyspnoea (472)
Abdominal discomfort (467)
What Other Drugs Cause Multiple sclerosis relapse?
DIMETHYL (6,852)
FINGOLIMOD (6,728)
NATALIZUMAB (6,478)
INTERFERON BETA-1A (5,931)
TERIFLUNOMIDE (4,745)
GLATIRAMER (3,695)
DALFAMPRIDINE (3,322)
OCRELIZUMAB (2,326)
OFATUMUMAB (1,525)
INTERFERON BETA-1B (1,229)
Which AZD-1222 Alternatives Have Lower Multiple sclerosis relapse Risk?
AZD-1222 vs AZELAIC ACID
AZD-1222 vs AZELASTINE
AZD-1222 vs AZELASTINE\FLUTICASONE
AZD-1222 vs AZELNIDIPINE
AZD-1222 vs AZILECT